Skip to main content
. 2020 Oct 17;9(10):3335. doi: 10.3390/jcm9103335

Table 2.

Clinical data of eight Italian APDS-1 patients.

P1 P2 P3 P4 P5 P6 P7 P8
Symptom leading to immunological evaluation Lymphoproliferation RRTI EN, Pneumonia RRTI HLH Lymphoproliferation Lymphoproliferation RRTI
Initial diagnostic hypothesis Lymphoma CVID-like CVID CVID HLH Lymphoma Lymphoma CID
Sinopulmonary infections Otitis, Pneumonia, Pneumonia Pneumonia Otitis, Pneumonia Otitis, Pneumonia Pneumonia Otitis, Pneumonia
Infections other than URTI Sepsis, episodic Candidiasis, recurrent Dental abscess Gastroenteritis Otomastoiditis
Viral infection VZV, episodic EBV, episodic HSV-1, episodic CMV, episodic EBV, persistent
Lymphadenopathies Diffuse Diffuse Diffuse Diffuse Diffuse Diffuse Cervical
Hepato/splenomegaly Hepatosplenomegaly Hepatosplenomegaly Hepatosplenomegaly Hepatosplenomegaly Hepatosplenomegaly Hepatosplenomegaly Splenomegaly
Autoimmunity Psoriatic dermatitis EN, Leucopenia, Thrombocytopenia, Thyroiditis Arthritis, Rash Hemolytic anemia Recurrent parotiditis
Allergy and asthma Asthma Asthma Asthma Wheezing
Gastrointestinal involvement IBD
Neurodevelopmental delay
Others FTT, Delayed puberty
Malignancy

Abbreviations: APDS-1: Activated Phosphoinositide 3-Kinase Delta Syndrome-1, CID: combined immune deficiency, CMV: cytomegalovirus, CVID: common variable immune deficiency, EBV: Epstein–Barr virus, EN: erythema nodosum, FTT: failure to thrive, HLH: hemophagocytic lymphohistiocytosis, HSV-1: herpes simplex virus 1, IBD: inflammatory bowel disease, RRTI: recurrent respiratory tract infection, VZV: varicella zoster virus.